80 Entecavir results in continued virologic and biochemical improvement and HBeAg seroconversion through 96 weeks of treatment in lamivudine-refractory, HBeAg(+) chronic hepatitis B patients (ETV-026)
- 30 April 2006
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 44, S36-36
- https://doi.org/10.1016/s0168-8278(06)80081-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: